Jessie Xie > Hogan Lovells International LLP > Beijing, China > Lawyer Profile

Hogan Lovells International LLP
31st Floor, Tower 3, China Central Place
No. 77 Jianguo Road, Chaoyang District
Beijing 100025
China

Work Department

Corporate

Position

Senior Associate

Career

As a senior associate in our Life Science and Health Care group, Jessie Xie has developed her practice to cover all types of regulatory work in the medical device, pharmaceutical, health care, food, and cosmetic industry sectors in China. She believes that the goal is not always to answer the question, but to help you achieve a competitive advantage and minimize regulatory risk.

Jessie is familiar with product approval, clinical trials, adverse event report, product recalls, labelling, advertising requirements, as well as compliance with Chinese laws and regulations relating to local manufacturing and global distribution of medical devices, drugs, food, and cosmetic.

She has worked with multinational medical device and pharmaceutical companies to spot regulatory risks, prevent problems from happening, and resolve them in a practical manner. Jessie has also worked with foreign universities to develop cooperative research programs in China, and has helped health care companies with the establishment of jointly operated hospitals. Jessie also advises extensively on privacy, data protection, encryption, commercial franchising, and direct selling practice – the areas that are rapidly changing and highly regulated in China.

Education

LL.M., University of Aberdeen, 2006

LL.B., Guizhou University, 2004

Lawyer Rankings

China > Life sciences and healthcare: foreign firms

(Rising stars)

Jessie XieHogan Lovells International LLP

Offering expertise on regulatory compliance, M&A deals in the life sciences space, sanctions and export controls, and the legal implications of clinical trials, Hogan Lovells International LLP provides a comprehensive service for clients in the Chinese market. The team is jointly led by Roy Zou, who is highly experienced in U.S. litigation matters involving Chinese companies or government agencies as respondents or defendants, and cross-border transactional and financing expert Lu Zhou. The regulatory compliance focussed Calvin Ding, who is experienced in both government sanctioned and internal compliance investigations, is also key, as is life sciences and healthcare sector antitrust expert Adrian Emch. Jessie Xie, who specialises in medical device and pharmaceutical clinical trials and product approval issues, is also well-recommended.